MANUEL YEPES
Neurology at Michael St, Atlanta, GA

License number
Georgia 056386
Category
Neurology
Type
Neurology
Address
Address
615 Michael St NE SUITE 505J, Atlanta, GA 30322
Phone
(404) 712-8358

Personal information

See more information about MANUEL YEPES at radaris.com
Name
Address
Phone
Manuel Yepes
650 Kimberly Ln NE, Atlanta, GA 30306
(404) 918-7033
Manuel Yepes
Atlanta, GA
(404) 872-0360
Manuel S Yepes
1021 Willivee Dr, Decatur, GA 30033
(404) 343-4748
Manuel S Yepes, age 57
650 Kimberly Rd, Atlanta, GA 30306
(404) 872-0360

Organization information

See more information about MANUEL YEPES at bizstanding.com

Manuel Yepes MD

615 Michael St, Atlanta, GA 30329

Industry:
Neurologist
Phone:
(404) 712-8358 (Phone)
Manuel Salvador Yepes

Professional information

See more information about MANUEL YEPES at trustoria.com
Manuel Yepes Photo 1
Dr. Manuel Yepes, Atlanta GA - MD (Doctor of Medicine)

Dr. Manuel Yepes, Atlanta GA - MD (Doctor of Medicine)

Specialties:
Vascular Neurology
Address:
1365 Clifton Rd NE, Atlanta 30322
(404) 778-3444 (Phone)
615 Michael St NE SUITE 505J, Atlanta 30322
(404) 712-8358 (Phone)
Conditions:
Cerebral Aneurysm, Cerebral Artery Thrombosis, Cerebral Vascular Disease, Dementia, Headache, Peripheral Nerve Disorders, Stroke
Certifications:
Neurology, 2001, Vascular Neurology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
1365 Clifton Rd NE, Atlanta 30322
615 Michael St NE SUITE 505J, Atlanta 30322
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
Pontificia Universidad Javeriana, Facultad De Medicina
Graduated: 1989


Manuel Yepes Photo 2
Manuel Yepes, Atlanta GA

Manuel Yepes, Atlanta GA

Specialties:
Neurology, Vascular Neurology, Neurological Surgery, Psychiatry
Work:
The Emory Clin
1365 Clifton Rd Ne, Atlanta, GA 30322 Atlanta Va Medical Center
1670 Clairmont Rd, Decatur, GA 30033 Emory Univ. Neurology
615 Michael St, Atlanta, GA 30322 Emory Medical Care Foundation
80 Jesse Hill Jr Dr SE, Atlanta, GA 30303
Education:
Pontificia Universidad Javeriana (1989)


Manuel Yepes, Md, Phd Photo 3
Manuel Yepes, Md, Phd

Manuel Yepes, Md, Phd

Location:
Greater Atlanta Area
Industry:
Hospital & Health Care


Manuel Yepes Photo 4
Tweak As A Therapeutic Target For Treating Central Nervous System Diseases Associated With Cerebral Edema And Cell Death

Tweak As A Therapeutic Target For Treating Central Nervous System Diseases Associated With Cerebral Edema And Cell Death

US Patent:
7939490, May 10, 2011
Filed:
Nov 8, 2005
Appl. No.:
11/718786
Inventors:
Jeffrey A. Winkles - Frederick MD, US
Manuel S. Yepes - Atlanta GA, US
Assignee:
University of Maryland, Baltimore - Baltimore MD
International Classification:
A61K 39/44, A61K 39/395, A61K 38/16, A61K 38/18, A61P 25/00
US Classification:
514 11, 4241331, 4241341, 4241411, 4241431, 4241451, 4241781, 514 76, 514 122, 514 133, 514 177, 514 212
Abstract:
The present invention is directed to compositions and methods for treating cerebral edema and cell death in neurological conditions characterized by disruption of the architecture of the neurovascular unit with increase in the permeability of the NVU, particularly for treating stroke. One aspect of the present invention relates to a composition comprising an agent that interferes with a TWEAK-mediated signaling pathway. Another aspect of the present invention relates to a method of using a composition which comprises an agent that inhibits Fn14 activity or Fn14 expression for the prevention and/or treatment of cerebral edema and cell death occurring in certain neurological conditions such as cerebral ischemia.


Manuel Yepes Photo 5
Methods And Compositions For Modulation Of Blood-Neural Barrier

Methods And Compositions For Modulation Of Blood-Neural Barrier

US Patent:
8147828, Apr 3, 2012
Filed:
Apr 17, 2007
Appl. No.:
11/736499
Inventors:
Ulf Eriksson - Stockholm, SE
Daniel Lawrence - Ann Arbor MI, US
Enming Joe Su - Ann Arbor MI, US
Dudley Strickland - Brookeville MD, US
Manuel Yepes - Atlanta GA, US
Linda Fredriksson - Hagersten, SE
Assignee:
Ludwig Institute for Cancer Research - New York NY
University of Maryland - Baltimore MD
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/395, C07K 16/28, C07K 14/71
US Classification:
4241301, 4241431, 5303871, 53038822
Abstract:
Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic cerebrovascular and related diseases in combination with antagonism of the PDGF signaling pathway. The inventive method and composition is particularly suitable for conjunctive therapy of ischemic stroke using tPA and an anti-PDGF-C antagonist or an anti-PDGFR-α antagonist.


Manuel Yepes Photo 6
Methods And Compositions For Modulation Of Blood-Neural Barrier

Methods And Compositions For Modulation Of Blood-Neural Barrier

US Patent:
2012015, Jun 21, 2012
Filed:
Feb 28, 2012
Appl. No.:
13/407270
Inventors:
Ulf Eriksson - Stockholm, SE
Daniel Lawrence - Ann Arbor MD, US
Enming Joe Su - Ann Arbor MD, US
Dudley Strickland - Brookville MD, US
Manuel Yepes - Atlanta GA, US
Linda Fredriksson - Stockholm, SE
Assignee:
LUDWIG INSTITUTE FOR CANCER RESEARCH - New York NY
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MD
UNIVERSITY OF MARYLAND, BALTIMORE - Baltimore MD
International Classification:
A61K 31/4439, A61K 31/4412, A61K 31/4709, A61K 31/404, A61P 7/10, A61K 31/416, A61K 31/502, A61K 38/49, A61P 7/02, A61P 9/00, A61K 31/506, A61K 31/444
US Classification:
424 9464, 514338, 51425218, 514346, 51425219, 514313, 514414, 514333, 514407, 514248
Abstract:
Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic cerebrovascular and related diseases in combination with antagonism of the PDGF signaling pathway. The inventive method and composition is particularly suitable for conjunctive therapy of ischemic stroke using tPA and an anti-PDGF-C antagonist or an anti-PDGFR-α antagonist.